Comer SD

Department of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA.

3 papers

ArticlePsychedelics

Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations.

Henningfield JE, Comer SD, Banks ML +13

Europe PMC2026
ArticlePsychedelics

Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review.

Kiluk BD, Kleykamp BA, Comer SD +24

Europe PMC2023
ArticlePsilocybin

Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.

Henningfield JE, Coe MA, Griffiths RR +10

Europe PMC2022